Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Accenture
Julphar
Cantor Fitzgerald
Chinese Patent Office

Generated: April 21, 2019

DrugPatentWatch Database Preview

Aurobindo Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA, and what generic and branded alternatives to AUROBINDO PHARMA drugs are available?

AUROBINDO PHARMA has three hundred and forty-six approved drugs.

There are thirty-four tentative approvals on AUROBINDO PHARMA drugs.

Drugs and US Patents for Aurobindo Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 206125-003 Mar 8, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 207182-002 Oct 30, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd ACETYLCYSTEINE acetylcysteine INJECTABLE;INTRAVENOUS 207358-001 Feb 29, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 202038-002 Sep 28, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065498-002 May 23, 2011 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 090349-002 Sep 20, 2010 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for AUROBINDO PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Fish and Richardson
Argus Health
Healthtrust
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.